AI - Grail

Pioneering multi-cancer early detection through ground-breaking solutions, achieving ISO 13485 Certification for robust development and manufacture of regulated medical products.

Logo of Grail
Last Audited At

About Grail

Grail is a pioneering biotech company that develops and provides ground-breaking solutions in the field of multi-cancer early detection (MCED). They have recently achieved ISO 13485 Certification, which underscores their dedication to implementing robust policies and procedures for the development and manufacture of regulated medical products. Grail's flagship product, Galleri®, is at the forefront of this innovation, with plans to initiate the REACH study to evaluate its clinical impact. The prospective, multi-center study aims to assess the added value of Galleri® in addition to currently recommended cancer screenings. Grail has presented their research on real-world implications of MCED at prominent industry events such as ISPOREurope and has been recognized as a top biopharma company by BioSpace.

Screenshot of Grail Website

Was this page helpful?

More companies

Count

Explore, model, and tell stories with real-time data using Count's dbt Cloud and Core integration. Version control, storytelling, reporting, user-friendly.

Read more

Earnest Analytics

Transforming data into actionable intelligence for Investors, Companies, and Consultants through real-time analysis and expert insights from Earnest Analytics.

Read more

Spark Cognition

Empowering industries to maximize performance, augment human intelligence, and achieve net-zero emissions through innovative AI solutions.

Read more

Tell us about your project

Our Hubs

London, United Kingdom

A global AI hotspot, thrives on innovation, diverse talent, and a dynamic tech ecosystem, offering unparalleled opportunities for AI engineers.

Munich, Germany

A vibrant AI hub, merges cutting-edge technology with rich cultural experiences, creating an inspiring environment for AI engineers.